ReInnervate
Sedgefield
About ReInnervate
ReInnervate Limited, a biotechnology company, engages in the development of enabling technologies that facilitate research into cell growth and function in vitro, primarily in the field of stem cell biology. Its technologies control the differentiation of stem cells and the formation of specific tissue types, as well as offers tools to develop diagnostics and treatments for neuro-degenerative diseases. The company was founded in 2002 and is based in Durham, the United Kingdom.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $7.6M
- Funding stage: M&A
- Last round: Series Unknown (May 2014)
- Website: reinnervate.com
- Phone: 44 1740 625266
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/reinnervate-1149852 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.